These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
423 related articles for article (PubMed ID: 31941260)
1. [Observation of the therapeutic and characteristic effects of terlipressin on refractory cirrhotic ascites]. Xing F; Li S; Zhang JJ; Sun CY; Huang JR; Gao ZL; Zhu TT; Zhao Q; Zhang H; Liu CH Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):982-988. PubMed ID: 31941260 [No Abstract] [Full Text] [Related]
2. AGA Clinical Practice Update on the Evaluation and Management of Acute Kidney Injury in Patients With Cirrhosis: Expert Review. Flamm SL; Wong F; Ahn J; Kamath PS Clin Gastroenterol Hepatol; 2022 Dec; 20(12):2707-2716. PubMed ID: 36075500 [TBL] [Abstract][Full Text] [Related]
3. Evaluation of the Acute Kidney Injury Network criteria in hospitalized patients with cirrhosis and ascites. Piano S; Rosi S; Maresio G; Fasolato S; Cavallin M; Romano A; Morando F; Gola E; Frigo AC; Gatta A; Angeli P J Hepatol; 2013 Sep; 59(3):482-9. PubMed ID: 23665185 [TBL] [Abstract][Full Text] [Related]
4. AGA Clinical Practice Update on the Use of Vasoactive Drugs and Intravenous Albumin in Cirrhosis: Expert Review. Garcia-Tsao G; Abraldes JG; Rich NE; Wong VW Gastroenterology; 2024 Jan; 166(1):202-210. PubMed ID: 37978969 [TBL] [Abstract][Full Text] [Related]
5. Terlipressin Plus Albumin Is More Effective Than Albumin Alone in Improving Renal Function in Patients With Cirrhosis and Hepatorenal Syndrome Type 1. Boyer TD; Sanyal AJ; Wong F; Frederick RT; Lake JR; O'Leary JG; Ganger D; Jamil K; Pappas SC; Gastroenterology; 2016 Jun; 150(7):1579-1589.e2. PubMed ID: 26896734 [TBL] [Abstract][Full Text] [Related]
6. The use of terlipressin in cirrhotic patients with refractory ascites and normal renal function: a multicentric study. Fimiani B; Guardia DD; Puoti C; D'Adamo G; Cioffi O; Pagano A; Tagliamonte MR; Izzi A Eur J Intern Med; 2011 Dec; 22(6):587-90. PubMed ID: 22075285 [TBL] [Abstract][Full Text] [Related]
7. Role of Terlipressin in Cirrhotic Patients with Ascites and without Hepatorenal Syndrome: A Systematic Review of Current Evidence. Bai Z; An Y; Guo X; Teschke R; Méndez-Sánchez N; Li H; Qi X Can J Gastroenterol Hepatol; 2020; 2020():5106958. PubMed ID: 32676484 [TBL] [Abstract][Full Text] [Related]
8. Early Versus Standard Initiation of Terlipressin for Acute Kidney Injury in ACLF: A Randomized Controlled Trial (eTerli Study). Jindal A; Singh H; Kumar G; Arora V; Sharma MK; Maiwall R; Rajan V; Tewathia HV; Vasishtha C; Sarin SK Dig Dis Sci; 2024 Jun; 69(6):2204-2214. PubMed ID: 38637454 [TBL] [Abstract][Full Text] [Related]
9. Terlipressin May Decrease In-Hospital Mortality of Cirrhotic Patients with Acute Gastrointestinal Bleeding and Renal Dysfunction: A Retrospective Multicenter Observational Study. Xu X; Liu B; Lin S; Li B; Wu Y; Li Y; Zhu Q; Yang Y; Tang S; Meng F; Chen Y; Yuan S; Shao L; Bernardi M; Yoshida EM; Qi X Adv Ther; 2020 Oct; 37(10):4396-4413. PubMed ID: 32860184 [TBL] [Abstract][Full Text] [Related]
10. Short-term mortality in patients with cirrhosis of the liver and acute kidney injury: A prospective observational study. Kumar U; Kumar R; Jha SK; Jha AK; Dayal VM; Kumar A Indian J Gastroenterol; 2020 Oct; 39(5):457-464. PubMed ID: 33175368 [TBL] [Abstract][Full Text] [Related]
11. Dobutamine reverses the cardio-suppressive effects of terlipressin without improving renal function in cirrhosis and ascites: a randomized controlled trial. Israelsen M; Dahl EK; Madsen BS; Wiese S; Bendtsen F; Møller S; Fialla AD; Jensen BL; Krag A Am J Physiol Gastrointest Liver Physiol; 2020 Feb; 318(2):G313-G321. PubMed ID: 31841026 [TBL] [Abstract][Full Text] [Related]
12. Comparison of the effect of terlipressin and albumin on arterial blood volume in patients with cirrhosis and tense ascites treated by paracentesis: a randomised pilot study. Moreau R; Asselah T; Condat B; de Kerguenec C; Pessione F; Bernard B; Poynard T; Binn M; Grangé JD; Valla D; Lebrec D Gut; 2002 Jan; 50(1):90-4. PubMed ID: 11772973 [TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of continuous terlipressin infusion in HRS-AKI in a transplant population. Reddy KR; Weinberg EM; Gonzalez SA; Izzy MJ; Simonetto DA; Frederick RT; Rubin RA; Fricker Z; Ikahihifo-Bender J; Harte M; Garcia S; Campbell K; Olofson A; Razavi RF; James JM; Patel H; Kim-Lee G; Witkiewicz S; Tobin W; Jamil K Liver Transpl; 2024 Oct; 30(10):1026-1038. PubMed ID: 38771635 [TBL] [Abstract][Full Text] [Related]
14. Impact of terlipressin infusion during and after live donor liver transplantation on incidence of acute kidney injury and neutrophil gelatinase-associated lipocalin serum levels: A randomized controlled trial. Kandil MA; Abouelenain KM; Alsebaey A; Rashed HS; Afifi MH; Mahmoud MA; Yassen KA Clin Transplant; 2017 Aug; 31(8):. PubMed ID: 28564127 [TBL] [Abstract][Full Text] [Related]
15. [Research progress of terlipressin in the treatment of cirrhotic ascites-related complications]. Liu CH; Xing F; Wang J Zhonghua Gan Zang Bing Za Zhi; 2019 Dec; 27(12):929-932. PubMed ID: 31941255 [TBL] [Abstract][Full Text] [Related]
16. Midodrine and albumin versus albumin alone for the secondary prophylaxis of acute kidney injury in a patient with cirrhosis and ascites. Sharma P; Puri P; Bansal N; Singla V; Kumar A; ShriHari AA; Arora A Eur J Gastroenterol Hepatol; 2021 Dec; 33(1S Suppl 1):e499-e504. PubMed ID: 34034268 [TBL] [Abstract][Full Text] [Related]
17. Effects of Chinese herbal cataplasm Xiaozhang Tie on cirrhotic ascites. Xing F; Tan Y; Yan GJ; Zhang JJ; Shi ZH; Tan SZ; Feng NP; Liu CH J Ethnopharmacol; 2012 Jan; 139(2):343-9. PubMed ID: 22107835 [TBL] [Abstract][Full Text] [Related]
18. Terlipressin Is Superior to Noradrenaline in the Management of Acute Kidney Injury in Acute on Chronic Liver Failure. Arora V; Maiwall R; Rajan V; Jindal A; Muralikrishna Shasthry S; Kumar G; Jain P; Sarin SK Hepatology; 2020 Feb; 71(2):600-610. PubMed ID: 30076614 [TBL] [Abstract][Full Text] [Related]
19. Impact of acute kidney injury on prognosis and the effect of tolvaptan in patients with hepatic ascites. Hiramine Y; Uto H; Mawatari S; Kanmura S; Imamura Y; Hiwaki T; Saishoji A; Oku M; Tokushige K; Maenohara S; Ido A J Gastroenterol; 2021 Jan; 56(1):54-66. PubMed ID: 32959093 [TBL] [Abstract][Full Text] [Related]
20. Effects of a single terlipressin administration on cardiac function and perfusion in cirrhosis. Krag A; Bendtsen F; Mortensen C; Henriksen JH; Møller S Eur J Gastroenterol Hepatol; 2010 Sep; 22(9):1085-92. PubMed ID: 20453655 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]